Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
- DOI
- 10.3389/fimmu.2022.1026473
- Published
- 2022-12-13
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2022.1026473,
title = {Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections},
author = {Mohamed Ibraheem Mahmoud Ahmed and Paulina Diepers and Christian Janke and Michael Plank and Tabea M. Eser and Raquel Rubio-Acero and Anna Fuchs and Olga Baranov and Noemi Castelletti and Inge Kroidl and Laura Olbrich and Bernadette Bauer and Danni Wang and Martina Prelog and Johannes G. Liese and Christina Reinkemeyer and Michael Hoelscher and Philipp Steininger and Klaus Überla and Andreas Wieser and Christof Geldmacher},
year = {2022},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2022.1026473},
url = {https://doi.org/10.3389/fimmu.2022.1026473}
}RIS
TY - JOUR TI - Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections AU - Mohamed Ibraheem Mahmoud Ahmed AU - Paulina Diepers AU - Christian Janke AU - Michael Plank AU - Tabea M. Eser AU - Raquel Rubio-Acero AU - Anna Fuchs AU - Olga Baranov AU - Noemi Castelletti AU - Inge Kroidl AU - Laura Olbrich AU - Bernadette Bauer AU - Danni Wang AU - Martina Prelog AU - Johannes G. Liese AU - Christina Reinkemeyer AU - Michael Hoelscher AU - Philipp Steininger AU - Klaus Überla AU - Andreas Wieser AU - Christof Geldmacher PY - 2022 JO - Frontiers in Immunology DO - 10.3389/fimmu.2022.1026473 UR - https://doi.org/10.3389/fimmu.2022.1026473 ER -
APA
Ahmed, M. I. M., Diepers, P., Janke, C., Plank, M., Eser, T. M., Rubio-Acero, R., Fuchs, A., Baranov, O., Castelletti, N., Kroidl, I., Olbrich, L., Bauer, B., Wang, D., Prelog, M., Liese, J. G., Reinkemeyer, C., Hoelscher, M., Steininger, P., Überla, K., Wieser, A., & Geldmacher, C. (2022). Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.1026473
Source records
- crossref · retrieved 2026-09-26T05:46:03.845Z